Delivery Order SPE2DR25D1106-SPE2DR26FJF7E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,716.12 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,388.84 to supply Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The order was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of December 19, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.60 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit-dose packaging of 10s, with a completion date of December 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,699.70 delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $17,203.01 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) with a firm fixed price structure. This contract, with an ultimate completion date of December 16, 2025, represents a competitive award with no set-aside designation and is performed from the contractor's Conshohocken, Pennsylvania location. The delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a $9,683.84 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10, with completion targeted for December 29, 2025. This competitively awarded, firm fixed price contract utilizes no set-aside designation and calls for performance at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,545.85 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This order, issued on November 20, 2025, with completion targeted for November 21, 2025, represents a firm fixed price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designations, reflecting open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with a ceiling value of $2,820.63 and an ultimate completion date of December 18, 2025. This is a firm fixed-price, non-set-aside delivery order performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF7EDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,418.00 delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules (100-count units) with a completion date of January 2, 2026. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's comprehensive IDC vehicle with DLA enables supply of a broad range of pharmaceuticals and medical commodities—including specialty medications, vaccines, and medical devices—to support Defense Health Agency operations and other federal healthcare systems globally. This delivery order represents routine pharmaceutical fulfillment under that strategic contract vehicle, supporting the federal government's medical supply chain requirements for antiviral medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 12/30/25 |